$1.145
+0.005 (+0.43%)收盘时
BON 资讯
BON 事件
Bon Natural Life Enters Cooperation Agreement with Tigerbone Group
Bon Natural Life entered into a cooperation framework agreement with Tigerbone Group. As part of this strategic initiative, the parties also announced plans to establish the "Bon Cooperation and Development Committee," which will serve as a central platform to advance collaboration in traditional Chinese medicine and life sciences through resource sharing and complementary strengths. Bon and Tigerbone Group will collaborate across traditional Chinese medicine products, life sciences research, and nutritional functional foods. Each party will retain its independent intellectual property rights and scientific research achievements, while jointly developing new products, technologies, and solutions to drive innovation and long-term value creation. Tigerbone Group is a diversified investment holding company with market channels across traditional Chinese medicine, the broader health sector, and financial services.
Bon Natural Life Develops Apple Polyphenol Anti-Aging Mask
Bon Natural Life announced the development of a premium anti-aging facial mask incorporating apple polyphenols as its core active ingredient and integrated with AI-enabled flexible bio-electronic technology. Leveraging advanced transdermal delivery systems, this product integrates plant-derived active ingredients with intelligent flexible electronics, creating a next-generation skin care solution designed to be non-invasive, painless, and suitable for at-home use. Apple polyphenols are extracted from premium apple pomace and contain polyphenolic compounds such as proanthocyanidins and quercetin. This approach is designed to address the absorption limitations typically associated with conventional topical skincare products. At present, the company has completed sample development and preliminary internal performance evaluations of the AI-powered flexible bio-electronic mask incorporating apple polyphenols. In the next phase, the company plans to initiate expanded third-party clinical testing while advancing product finalization and optimizing large-scale manufacturing processes.
Bon Natural Life Launches New Product and Signs $12M Collaboration Agreement
Bon Natural Life announced the launch of a new kombucha-inspired product and a strategic collaboration with Shaanxi Qingshengyuan Health Industry, a distributor of health products in China. The two parties entered into a non-exclusive strategic sales agreement. The term of the agreement is 24 months with a total contract value of $12M. Pursuant to the agreement, Qingshengyuan will sell and distribute Bon's high-tea-pigment products across Greater China.
Bon Natural Life reveals $26M partnership deal with Beijing Huahai Keyuan
Bon Natural Life announced a non-exclusive cooperation agreement with Beijing Huahai Keyuan Technology Co. Ltd., a health products distributor in China. The term of the agreement is 36 months with a total contract value of $26M. Pursuant to the agreement, Huahai Keyuan will sell and distribute BON's second-generation tea pigment-based digestive health products in Greater China.
Bon Natural Life Signs $18M Partnership Agreement in China
Bon Natural Life has entered into a non-exclusive cooperation agreement with Beijing Huahai Keyuan, a health products distributor in China. The term of the agreement is 24 months with a total contract value of $18M. Pursuant to the agreement, Huahai Keyuan will sell and distribute BON's second-generation Apple Series health products across Greater China. BON's second-generation Apple Series delivers 80% higher bioactivity than its predecessor by improving the efficiency of the active ingredient extraction. Early market validation shows comparable apple polyphenol blends generating over $40M in monthly sales.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。